Biotechnology firm Humacyte’s (HUMA) shares have declined since the company presented its fourth-quarter and full-year 2024 ...

For fiscal year 2025, Puma Biotechnology projects NERLYNX product revenue net to be between $192 million and $198 million, with a gross to net adjustment between 20.5% and 21.5%. The company also ...

Penza Oblast of Russia offers Belarus cooperation in biotechnology, agriculture, machinery supplies, and also in the implementation of cultural projects, Governor of Russia’s Penza Oblast Oleg ...

Biotechnology Innovation Awards 2025 A' Biotechnology and Bioengineering Design Award reveals extensive benefits package aimed at recognizi ...